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ABSTRACT
Undiagnosed hypertension continues to be a growing concern worldwide leading to
cardiovascular disease and other chronic illnesses and can contribute to death. The prevalence of
hypertension continues to increase even with guidelines on screening, hypertension education,
disease prevention, disease maintenance, and management.
The purpose of this project was to determine if the implementation of a workplace blood
pressure screening program would improve hypertension knowledge and reduce the burden of
hypertension within workplace. A descriptive, cross-sectional design using convenience
sampling was conducted. Participants were screened by measuring blood pressures, and the
Hypertension Evaluation of Lifestyle Management scale (HELM) was utilized to assess
participants’ hypertension knowledge pre/post intervention. Home Blood Pressure Monitoring
(HBPM) devices were utilized for two weeks, followed by a 30-day follow-up. Paired t-test of
pre/post systolic blood pressure (SBP) and diastolic blood pressure (DBP) showed significant
improvement in DBPs only. Lastly, the paired t-test of the HELM scale scores showed
significant changes in hypertension knowledge post intervention. Findings from this Doctor of
Nursing Practice Project resulted in a significant short-term improvement of DBP and increased
hypertension knowledge. This project laid a foundation for future studies on the importance of
screening practices, use of patient specific education (evidence-based), and the importance of the
use of HBPM in hypertension screening.
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CHAPTER I
Introduction
Hypertension affects 31 percent of adults in the United States (Reza, Soeryo, & Soerarso,
2018). According to the Center for Disease Control (CDC), between 2013 and 2014, 40.3 million
and 3.7 million visits were made to hospital outpatient services and clinics, respectively, and the
primary diagnosis was critical hypertension. The American Heart Association (AHA) defines
critical hypertension as any individual with a systolic blood pressure (SBP) of 180 or higher and
diastolic blood pressure (DBP) of 120 or higher (2019). The prevalence of controlled
hypertension was 53.0%; however, individuals aged 18 to 39 years were less likely to have
controlled hypertension than those aged 60 years and older (Reza, Soeryo, & Soerarso, 2018).
Hypertension prevalence remained unchanged from 1999 to 2014 despite hypertension
regulation improved according to the CDC (Reza, Soeryo, & Soerarso, 2018).
Hypertension, also known as high blood pressure, is a chronic condition which is defined
as a condition that lasts 12 months or longer and meets one or both of the following tests: 1) it
places limitations on self-care, independent living, and social interactions; and 2) it results in the
need for ongoing intervention with medical products, services, and specialized equipment
(Healthcare Cost and Utilization Project [HCUP], 2018). Having a chronic disease profoundly
impacts an individual's quality of life because of its prolonged course. The disease does not
resolve spontaneously, for which a complete cure is rarely achieved even with treatment. The
National Center for Chronic Disease Prevention and Health Promotion (NCCDPH) 2018 report
revealed that chronic diseases accounted for 3.3 trillion dollars of the nation's annual healthcare
costs. The results above imply that the burden of preventable chronic diseases is straining our
nations' health and economy, which can be reduced through early intervention and prevention.
1

Problem and Significance
Hypertension increases risks for cardiovascular disease (CVD), heart failure, kidney
disease, cerebrovascular disease, atrial fibrillation and can lead to multi-system organ damage if
not managed (Rahman et al., 2019; AHA, 2018). CVD and type II diabetes mellitus are two of
the many conditions that have contributed to approximately 60% of deaths in countries with high
incomes (Aginsky, Constantinou, Delport, and Watson, 2017). The effects of hypertension and
related morbidity for the healthcare system increase the cost of providing long-term care and
treatment, including hospitalization and early retirement due to disability (Rapsomaniki, Timmis,
& George, et al., 2014).
The AHA/American College of Cardiology (ACC) groups blood pressure into 5
categories (Whelton et al., 2017).:
1. Normal- SBP less than 120 mm Hg & DBP less than 80 mm Hg
2. Elevated blood pressure- SBP 120-129 mm Hg & DBP less than 80 mm Hg
3. Stage I Hypertension- SBP 130-139 mm Hg & DBP 80-89
4. Stage II Hypertension- SBP 140 mm Hg or higher & DBP 90 mm Hg or higher
5. Stage III Hypertension- SBP higher than 180 mm Hg & DBP higher than 120 mm Hg
Hypertension is a significant public health concern in the United States, affecting people
of all ages and continues to cause worsening of chronic health conditions (Abu, Aboumatar,
Carson, Goldberg, & Cooper, 2018). One of every three adults has high blood pressure; only
about half of individuals with high blood pressure have their medical condition under control
(Abu, Aboumatar, Carson, Goldberg, & Cooper, 2018). One thousand one hundred deaths per
day are related to high blood pressure, and it costs the United States about $48.6 billion each
year (CDC, 2019). Many multi-factorial causes lead to high blood pressure, such as diabetes,
2

inadequate dietary intake, sedentary lifestyles, socio-economic factors, and many other concerns
(CDC, 2019).
Another critical consideration is the workplace's effect on high blood pressure; when
considering long work hours, work stressors, and psychosocial factors. The AHA recommends
workplace blood pressure screenings because many individuals live with high blood pressure and
are unaware of the disease (2018). Clemow et al. (2018) stated that psychosocial risk factors,
including hostility, chronic psychosocial stress, nonadaptive coping, depression, work stress, and
low socioeconomic status, contribute to the development of hypertension. For most individuals,
it has been observed that blood pressure tends to be highest during hours of work; specifically,
an individuals’ blood pressure tends to be higher when at work than on a day off from work
(Williams, 2018).
Healthcare providers recommend annual wellness screenings to prevent and aid in the
early diagnosis of many diseases; however, many people still believe that yearly wellness visits
are unnecessary (Earnest & Church, 2017). Fortunately, there are guidelines in place for
hypertension. Specifically, the U.S. Preventive Services Task Force (2015) recommends starting
screening for high blood pressure in individuals 18 years of age and older. Suppose healthcare
screenings can be increased in the workplace, specifically focusing on blood pressure control and
educational compliance. In that case, there is a potential for improved patient health outcomes.
The AHA/ACC/CDC described criteria for successful hypertension management
algorithms and advocates the creation of algorithms that can be incorporated into a system-level
approach to hypertension and considered the different practice settings and patient populations.
The recommended goal is for hypertension is 139/89 mm Hg or less (Go et al., 2014).
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An individual's educational background, knowledge, and beliefs play a significant role in
adherence to healthcare recommendations and health outcomes. Patient-centered education and
worksite screening programs could help bridge the gap in care and improve the hypertension
epidemic in the United States (Lattimore, 2010; Legorreta, Schaff, Leibowitz, and Meijgaard,
2015). Utilizing screening in the workplace could offer a potential solution to failed annual
healthcare screenings and the early identification of high blood pressure. Monitoring for family
history, co-morbidities such as diabetes, increased body mass index (BMI), and providing timely
patient-centered education could positively improve outcomes, reduce medical expenditure, and
improve the overall quality of life (Legorreta, Schaff, Leibowitz, and Meijgaard, 2015).
Prevention can be achieved by identifying individuals with increased risks for hypertension
and other non-communicable diseases. Non-communicable diseases, including hypertension,
diabetes type 2, and CVD, can be prevented with screening programs in and outside of the
workplace (Tryon et al., 2014). To identify individuals at risk for hypertension and provide the
necessary tools for preventing and treating the disease. We must recognize the barriers
preventing early screening, diagnosis/treatment of the disease, and evaluate current workplace
screening practices (Legorreta, Schaff, Leibowitz, and Meijgaard, 2015). Providing education
about the effects of unhealthy dietary patterns, physical inactivity, and the importance of health
screenings can improve patient outcomes (Tryon et al., 2014).

4

Problem Statement
Hypertension is a disease that many people suffer from without noticeable signs and
symptoms, which later can lead to significant CVD, renal disease, and at its worse, death (Seibt
et al., 2018). Hypertension is a modifiable disease, and screening in the workplace could increase
early detection and disease management. Screening for hypertension could provide early
identification, treatment, individualized patient education, and lifestyle modification.
Undiagnosed elevated blood pressure and undiagnosed stage 1 hypertension can lead to disease
progression, resulting in the need for medication management. If diagnosed early, it can allow
for early intervention in the disease process, preventing CVD and other organ damage, and the
potential treatment with medications (Seibt et al., 2018). It is critical to screen for high blood
pressure and other modifiable diseases in the work setting to reduce the burden of hypertension
and medical conditions related to having high blood pressure (Legorreta, Schaff, Leibowitz, and
Meijgaard, 2015). Most adults go to work and spend many hours in the workplace setting;
therefore, it is an ideal place to implement a hypertension screening program and other
preventive health screenings. Developing a worksite blood pressure screening program could
help increase early identification of elevated blood pressure and undiagnosed stage 1
hypertension, lead to disease prevention and early management, and potentially reduce other
CVDs and non-communicable diseases.
Purpose Statement
To reduce the burden of elevated blood pressure and undiagnosed stage 1 hypertension
in the workplace. This project aims to evaluate the efficacy of the implementation of a
hypertension screening program in the workplace/occupational setting for adults ages 18–65.
5

This DNP Project will utilize evidenced-based practice guidelines and recommendations to offer
blood pressure screening, treatment recommendations, and hypertension education.
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CHAPTER II
This project aims to evaluate the efficacy of the implementation of a hypertension
screening program in the workplace/occupational setting for adults ages 18 – 65. It is critical to
screen for elevated blood pressure and undiagnosed stage 1 hypertension since hypertension is
missed in diagnosis, leading to compounding medical conditions and sometimes death (Seibt et
al., 2018). This chapter provides a review of the relevant literature on hypertension research from
the last three to five years. In order to complete this chapter, the following subsections were
developed: (a) Hypertension Prevalence and Consequences, (b) Barriers to Early Diagnosis and
Treatment, (c) Current Workplace Screening Practices, (d) Hypertension Treatment Guidelines,
(d.i) Screening Recommendations, (d.ii) Nutritional Guidelines, and (d.iii) Physical Activity.
These discussions will be followed by (e) Significance to Nursing, (f) Synthesis of Available
Evidence, (g) Needs Assessment and Description of Project, (h) Population Identification, (i)
Identification of Project Sponsor and Key Stakeholders, (j) Assessment of Available Resources,
(k) Cost-Benefit Analysis, (l) Scope of the Project, and (m) Mission Goals and Objective
Statements.
Review of the Literature
Hypertension Prevalence and Consequences
Hypertension increases the risks for severe health conditions, including heart attacks,
stroke, heart failure, and kidney disease (CDC, 2019). Many of these risks are modifiable, and, in
many cases, some are not; but this does not mean we cannot attempt to take the necessary steps
with disease prevention (CDC, 2019). In 2013, there were more than 360,000 deaths, and in
2014, 410,000 deaths in the United States where hypertension was stated as the contributing or
7

primary cause of death (CDC, 2019). Hypertension prevalence in the state of Nevada was 26.5%,
and in 2017, it increased to 30.0%, with a higher prevalence in men (36.5%) than women
(28.9%; CDC, 2019). The AHA (2018), stated that more than half of Americans are unaware of
their hypertension, and the best way of knowing is by merely having your blood pressure
checked.
During 2015-2016, the prevalence of hypertension was at almost 30 percent of the
population, but significantly higher for men than women, increasing within each demographic
(Dorans et al., 2018). There are many different forms of hypertension. This disease is shared
with other ailments and chronic illnesses, often making it part of a treatment plan rather than
receiving an individual treatment option (de Beus, 2017). Overall, hypertension is proliferating
within the population. The prevalence of the disorder leads many healthcare workers to urge for
macro-collaboration on tackling this crisis (Mills et al., 2016).
In recent years, the concentration of academic research into hypertension has led to many
different types of studies being conducted. Many of these studies focus on how one develops
hypertension and whether environmental issues can contribute (Usher et al., 2018; Vinceti et al.,
2019; Mensah et al., 2019). These studies have found that demographic factors such as age, race,
and socioeconomic status can significantly impact one's potential for developing hypertension
(Usher et al., 2018; Vinceti et al., 2019). These same demographic factors often control whether
or not an individual can receive the appropriate care for hypertension, with primarily Hispanic
and Black families suffering from a lack of affordable healthcare or access to lifestyle changes to
mitigate the issue (Mensah et al., 2019). These issues further compound for immigrants from
diverse racial backgrounds, suggesting that these populations may need to receive the
appropriate care and help afforded to their Caucasian counterparts (Mensah et al., 2019).
8

Most hypertension can be controlled with lifestyle changes and antihypertensive agents.
However, there remains a significant sub-demographic of patients with resistant hypertension
that cannot achieve optimal blood pressure control and suffer worse outcomes, suggesting that
this continues to be a misunderstood disorder (Ferro, 2017). Many of these individuals have
often been found to be significantly overweight and reluctant to change their poor physical health
status with lifestyle changes (Manios et al., 2018). Poor physical health has led some researchers
to study the eating patterns of those suffering from hypertension, with results suggesting that
those who eat more later in the day are more likely to develop the disorder (Leech et al., 2019).
However, even these studies are often finished with further evaluation needed, meaning that
many of the assumptions of hypertension are not technically scientifically valid (Canoy et al.,
2016).
Shen (2020) suggested a lack of public knowledge concerning the vast frequency of
hypertension in the United States population. Overall, the research into hypertension prevalence
and consequences is fairly set: hypertension is incredibly common, and the consequences of no
or mistreatment are premature death, which is precisely why further research is needed to
understand how best to screen for hypertension in standard settings, such as the workplace
(Rehkopf et al., 2017). The following section continues with a discussion of the barriers to early
diagnosis and treatment, as this is the core theme identified through the overview research into
the prevalence and consequences of hypertension.
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Barriers to Early Diagnosis and Treatment
Hypertension has been referred to as the silent killer due to many individuals showing no
significant symptoms of the disease (AHA, 2018), many individuals have the impression that
their health is in good condition and there is no need for a medical examination unless ill or
symptomatic (CDC, 2019). Asymptomatic hypertension is one of many causes of delayed
diagnosis and treatment, leading to multiple comorbid conditions related to hypertension (AHA,
2018). The healthcare provider must have an accurate blood pressure reading when diagnosing
hypertension. There are many factors for abnormal blood pressure readings, which should be
considered before diagnosis and treatment.
Accurate blood pressure reliability is an essential element that we must consider when
diagnosing hypertension. Healthcare providers utilize the diagnostic measurements taken by staff
and sometimes themselves. Ensuring these results are accurate, staff must be trained to collect
blood pressure readings using the appropriate size cuff, correct placement, allowing the patient to
sit for several minutes is critical (Carter & Kaylor, 2016). Misdiagnosis related to inaccurate
measurements or false readings could be detrimental to patients if the wrong medications or
treatment plan is prescribed. White Coat Syndrome is another condition the healthcare provider
must think about when considering a diagnosis of hypertension. Whitecoat syndrome is the
elevation of blood pressure outside of average values in the clinical setting (Carter & Kaylor,
2016). To increase the early diagnosis and treatment of hypertension, The European Society of
Cardiology/European Society of Hypertension (ESC/ESH) changed guidelines for 2018. The
ESC/ESH recommended increased use of ambulatory blood pressure monitoring and home blood
pressure monitoring (HBPM) to aid in diagnosing white coat syndrome (Pioli, Ritter, de Faria, &
Modolo, 2018). However, these guidelines have several barriers for some of the patient
10

population and health providers, who often fail to utilize ambulatory and HBPM before
diagnosing hypertension.
Barriers related to ambulatory blood pressure monitoring were identified as (a) challenges
in accessing testing, (b) increasing cost of testing individuals, often leading many to refuse the
service, (c) concerns about the willingness or ability of patients to complete tests, and (d)
concerns about the accuracy and benefits of testing, which has frequently been called into
question by healthcare professionals (Kronish et al., 2017). Other barriers to HBPM were noted
as (a) concerns about compliance with the correct test protocol, (b) accuracy of tests results as
these machines are often considered faulty or manipulated to meet the purposes of insurance
companies who issue them, or (c) out-of-pocket costs of home blood pressure devices, and (d)
time needed to instruct patients on HBPM protocol, all of which costs the healthcare provider
and patient a significant amount of money (Kronish et al., 2017). It was reported that 19% of
physicians stated they would utilize ambulatory blood pressure monitoring. However, half of
these physicians never ordered ambulatory blood pressure monitoring for their patients to aid in
diagnosing hypertension (Carter & Kaylor, 2016). As a result of the findings of this DNP project,
Kronish et al. (2017) suggested that efforts to increase the use of ambulatory and HBPM by
primary care providers (PCP) in the United States should prioritize increasing the financial and
personnel resources available for testing and addressing provider concerns about patients' ability
to conduct high-quality tests. This finding is significant, as it suggests that the root cause of
hypertension prevalence is the cost of healthcare in the United States, which is likely the cause of
most medical issues and consistent failures by medical professionals in the United States
(Kronish et al., 2017).
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Clinical and therapeutic inertia is another barrier to hypertension treatment initiation and
management. Lebeau et al. (2014) defined clinical and therapeutic inertia as a failure of the
healthcare provider to initiate or intensify therapy when goals are not reached. Clinical and
therapeutic inertia can happen for several reasons: patients coming in for specific sick visit
complaints or having multiple issues, causing the provider to fail to recognize or address
hypertension (Lebeau et al., 2014). Failure to acknowledge or educate could cause hypertension
non-adherence due to a lack of knowledge. Overestimation of care is a second cause for failure
to treat, target almost reached, which is considered a soft reason, and lack of training were other
considerations why clinical and therapeutic inertia occurred (Lebeau et al., 2014).
Patient non-adherence is another barrier to hypertension management and treatment. It is
most prevalent in African Americans, individuals with lower incomes, and less education
(Legorreta, Schaff, Leibowitz, and Meijgaard, 2015). Khatib et al. (2014) found that patients'
lack of knowledge of the seriousness of the disease and disease management was a consistent
barrier. Many providers also reported that lack of motivation about achieving controlled blood
pressure and difficulty addressing healthy behaviors were concerns. Stating it lead to negative
beliefs about the consequences of medication adherence, guidelines, and recommendations
(Khatib et al., 2014). Providing patients with patient-centered therapeutic education is
recommended to improve patient outcomes and compliance (Barnason et al., 2017).
Other researchers agree that the barrier to the treatment of hypertension is global, with
nations like Nepal also finding that lifestyle had a detrimental impact on care (Shrestha et al.,
2018; Zack et al., 2016). However, in developing nations and rural communities, it is often the
dissemination of data that limits the treatment of hypertension. For example, Shrestha et al.
(2018) found that the main barriers to hypertension care in emerging economies were: (a) limited
12

public knowledge of the disorder, which meant that things like (b) a lack of symptoms stopped
many individuals from (c) taking their medication, due to (d) low perceived seriousness of the
disease. Shrestha et al.'s (2018) research is significant, as it sheds light on the number of studies
into hypertension coming from emerging economies and nation-states outside of the United
States.
Despite the perception that many of these nations do not have the same demographic
makeup as the United States, studies like those conducted by Zack et al. (2016) found that the
same issues cause hypertension worldwide. These issues include obesity, being overweight,
inadequate physical activity, and limited access to healthcare. Zack et al.'s (2016) study was
conducted in sub-Saharan Africa but found that much of the community-based screening
programs reflected processes used in the United States. Despite this, the same issues with cost,
insurance coverage, and a lack of patient education were the core barriers to help-seeking and
appropriate care of hypertension (Zack et al., 2016). Nonetheless, developing countries also
represent a great source of primary evidence for understanding barriers to treatment, which
seemingly include reasons why treatment is often unhelpful (Galson et al., 2017; Ibrahim (2018;
Perera et al., 2019). This finding is significant as it suggests that studies from outside of the
United States may contain appropriate data to mitigate the impact of hypertension on the
American population (Ogna & Burnier, 2018).
Park et al.'s (2019) study was significant as it sheds light on the importance of
hypertension being a universal issue, not limited to race, age, or gender. Sociodemographic,
health-behavior, biomedical, and health status factors are associated with awareness of
hypertension, which directly relates to whether or not an individual will seek treatment Park et
al., (2019). Research suggested that, among hypertensive adults, only 65.2 percent were aware of
13

their condition and were receiving the appropriate treatment with antihypertensive medications
(Park et al., 2019). Being of a younger age group was identified as an essential barrier to
diagnosing and treating hypertension, as younger people assume that they are healthy until a
significant medical issue forces them to see otherwise (Park et al., 2019). Although there were
slight differences between participants below age 65 and above 65 years. Higher risks of being
untreated or unknowingly having hypertension were also associated with the male gender, lower
education levels, unhealthy behaviors, and perceived better health conditions (Park et al., 2019).
This is a significant finding as hypertension is a chronic disease that requires a life-long
treatment program, even for asymptomatic patients (Ogna & Burnier, 2018). Heinert et al. (2020)
has similar conclusions as Park et al. (2019) that all populations are at risk of these barriers, and
no single demographic or population of individuals should be ignored in breaking down such
barriers.
Self-management of hypertension is unsuccessful unless the individual has received a
considerable amount of information on the best course of treatment and has completely
overhauled their lifestyle to accommodate this error in their internal functioning (Long, Ponder,
& Bernard, 2017). However, the financial and time-cost of performing such a macro-overhaul in
one's lifestyle is often the main barrier to such personal successes. Therefore, a top-down
approach to eradicating these issues may be the only option for healthcare workers (Long et al.,
2017). Carrico (2018) found that children and young adults need to be regularly screened for
hypertension which is inherently underutilized globally because hypertension remains a
misunderstood and under-recognized disorder. Carrico (2018) developed and deployed a
hypertension awareness program to increase early awareness of hypertension and found that
hypertension is a more than manageable disorder and can be taught to individuals within the 19
14

to 30 age range with success. It may be that such programs are the solution to the present barriers
to care discussed through the rest of this section of the study.
Nurses are often the first port-of-call for individuals seeking a diagnosis or treatment of
hypertension. Specifically, the role of registered nurses and nurse practitioners in improving
hypertension control has expanded over the past 50 years of healthcare practice (Himmelfarb et
al., 2016). Besides the importance of nurses' role in patient education, it has expanded to become
one of the most effective strategies to improve blood pressure control. However, it does not
account for the existing barriers in the treatment of hypertension (Himmelfarb et al., 2016). As a
result, the patient-centered, multidisciplinary team is a crucial feature of effective care models
that have been found to improve care processes and control rates (Himmelfarb et al., 2016).
Himmelfarb et al. (2016) stated that nurses must lead clinic and community-based research to
improve the hypertension quality gap and ethnic disparities by holistically examining social,
cultural, economic, and behavioral determinants of hypertension outcomes and designing
culturally sensitive interventions to address these determinants. The following section discusses
the current workplace screening practices of hypertension.
Current Workplace Screening Practices
Shen et al. (2018) examined the prevalence, awareness, treatment, and control of
hypertension, along with associated risk factors, within the Chinese working population. The
results of this DNP project revealed the prevalence of hypertension was 23.3 percent; among the
hypertensive, 47.8 percent were aware of their condition, 20.6 of these individuals were in
regular treatment, but only 8.5 percent had controlled hypertension (Shen et al., 2018). This DNP
project revealed substantial room for improvement in hypertension diagnosis and treatment
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among the employees, and according to Shen et al. (2018), effective intervention programs are
urgently needed at the workplace. However, utilizing hypertension intervention tools and
research from other countries could assist with blood pressure control in the United States.
Clemow et al. (2018) furthered the argument put forward by Shen et al. (2018) and stated
that workplace programs have the potential to be exceptional dissemination vehicles. The
prevalence in workplace care for hypertension revolves around screening (Bali et al., 2018).
Legorreta and colleagues study revealed that work screening programs within the United States
resulted in 68.3% of 6458 employees with a new hypertension diagnosis within 30 days. 60% of
employees received new anti-hypertensive prescriptions within 1-2 months post-screening,
suggesting that workplace screenings can be a valid screening route for hypertension and other
non-communicable diseases (2015). This led to the development of programs like May
Measurement Month, a global program that screens individuals for hypertension (McDonnell et
al., 2019). Many workplace factors contribute to hypertension, with more than 22 million
workers in the United States exposed to hazardous noise levels and other external factors
(Kuehn, 2018). Despite this, there is a significant limitation on the number of interventions in the
workplace to tackle these risks (Bali et al., 2018).
Employer-sponsored interventions and screening for hypertension may be necessary to
reduce the cost that hypertension represents to the general population (Iakobova et al., 2019).
Digital health tools have been suggested as an excellent means of assisting in this process.
Research conducted by Senecal et al. (2018) suggested that digital health tools could efficiently
serve as adjuncts to traditional pharmaceutical and lifestyle-based interventions and become a
constant screening method for workplaces and employees alike. Overall, the study found that
users of digital health intervention (DHI) had significant improvements in SBP, DBP, and BMI
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after the one-year intervention was completed (Senecal et al., 2018). Senecal et al. (2018)
research is significant as it has been supported by the World Health Organization (WHO), which
agrees that workplaces have to be the center of screening for disorders like hypertension,
particularly when they are often the source of additional stress and other factors that increase the
risk of hypertension (Wolf et al., 2018).
Adults spend most of their time in the workplace; they often spend most of their waking
hours in their place of work, depending on this environment to support them financially, but also
to give them the appropriate time off and healthcare (Wolf et al., 2018). There is evidence that
workplace hypertension is more related to job stress. However, Legorreta and colleagues found
that individuals with workplace hypertension tend to have more elevated blood pressures at their
healthcare visits than individuals who do not have hypertension while at work (2015). Workplace
wellness programs have been used worldwide and are widely implemented to promote employee
health outcomes and reduce health costs (Cheon, Naufal, & Kash, 2020). However, some
researchers have agreed that little is known about how the different designs used in wellness
programs matter for best promoting positive employee health outcomes specifically, Cheon et
al., (2020) study identified those effective designs within the scope of workplace wellness
programs, which result in positive employee health outcomes. The results suggest that, unlike the
mixed-effects in diabetes and hypertension prevention programs, the nutrition program, which
exhibited a high level of topic relevance, impact, and intensity, significantly decreases SBP,
DBP, glucose, and cholesterol, which improves health outcomes. This DNP project prompts
health educators to consider the comparative effectiveness of workplace wellness programs for
maximized impact on employees’ health outcomes. Designing wellness programs with high topic
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relevance, influence, and intensity should be emphasized in implementing workplace wellness
programs (Cheon et al., 2020).
Screening Recommendations
Hypertension is the leading cause of death for patients with other comorbidities;
therefore, screening for hypertension is a core requirement for all medical professionals with
patients presenting with symptoms (Morrisroe et al., 2017). Researchers suggested that the best
means of reducing the prevalence of hypertension is to conduct annual screenings with an
echocardiogram. However, adherence to these guidelines is low amongst physicians across the
United States (Morrisroe et al., 2017). Although the United States Preventative Service Task
Force recommends that all adults be screened for hypertension, the disorder continues to affect
one in three Americans (Viera, 2017). Most patients whose blood pressure is consistently
elevated should receive regular monitoring to confirm the diagnosis of hypertension. However,
many of these issues are ignored due to the external stressors assumed to result in high blood
pressure, such as an intensive work environment (Viera, 2017).
Anker et al. (2018) discussed how the screening and treatment of hypertension has a
direct impact on the likelihood of premature death due to CVD. Overall, there are consistent
arguments and findings throughout academic literature that shed light on the vast limitations in
understanding hypertension screening and what practitioners should be looking for within each
patient (Saygin & Domsic, 2019). What can be agreed from this section of research is the
necessity of screening to mitigate ongoing disorders; however, further research is needed to
establish how this is best achieved within the vastly diverse demographics that hypertension
embodies (Lewis, Shatat, & Phillips, 2017).
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Hypertension Treatment Guidelines
The Eighth Joint National Committee (JNC 8) recommended new guidelines for the
screening and treatment of hypertension in 2017; these guidelines are reviewed and updated
every couple of years or more as needed (Whelton et al., 2017). The term pre-hypertension was
removed and replaced with elevated blood pressure (Whelton et al., 2017). Other
recommendations included: (a) use of BP averages of ≥2 readings obtained on ≥two occasions,
also with lifestyle change and non-pharmacological interventions, (b) if a patient has elevated
blood pressure, lifestyle modifications should be recommended, (c) out of the office, and home
monitored blood pressures are recommended to aid in diagnosis and blood pressure management,
(d) treatment with pharmacological methods are recommended for individuals with an SBP
>140/90 mm Hg and DBP > 90 mm Hg, with/without diabetes and chronic kidney disease, (e)
pharmacological treatment recommended for adults 60 years of age an older with a BP > 150/90
mm Hg, (f) initiating drug treatment with an angiotensin-converting enzyme inhibitor,
angiotensin receptor blocker, calcium channel blocker, or thiazide-type diuretic in the nonblack
hypertensive population, including those with diabetes, (g) initiating drug treatment with an
angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, calcium channel blocker,
or thiazide-type diuretic in the nonblack hypertensive population, including those with diabetes,
(h) initial or add-on antihypertensive therapy with an angiotensin-converting enzyme inhibitor or
angiotensin receptor blocker in persons with chronic kidney disease to improve kidney outcomes
(Whelton et al., 2017).
The recommendations listed above are evidenced-based guidelines for the management
and treatment of hypertension, but not for all patients (Whelton et al., 2017). However, these
guidelines should never replace clinical judgment and assessment of the individual patient's
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needs (Whelton et al., 2017). Lackland et al. (2018) and Jangamani and Sundar (2018) stated that
hypertension is the most common modifiable risk factor related to CVD, renal dysfunction,
stroke, and many other disorders.
As a result, the guidelines for treatment should consistently consider the prevalence of
these other disorders and be developed to mitigate them (Jangamani & Sundar, 2018; Williams et
al., 2019). The recommended guidelines should guide treatment decisions with patients at risk
for and with hypertension. It is also recommended that patients are educated on physical activity
and given detailed nutritional guidance to reduce blood pressure (Whelton et al., 2017). The
following section continues with a discussion of dietary recommendations.
Non-pharmacological lifestyle modification interventions are highly beneficial in
reducing the symptoms associated with hypertension (Ozemek et al., 2017). These lifestyle
modifications include, but are not limited to, physical activity, dietary changes, weight loss,
reducing alcohol consumption, and smoking cessation, and are effective strategies in lowering
resting blood pressure in prehypertensive or hypertensive patients (Ozemek et al., 2017).
However, the limited time shared between a physician and a patient is not adequate to instill an
adoption of lifestyle management practices for reducing the negative impacts of hypertension,
which means that many individuals are not exposed to the nutritional practices best used to
reduce risk (Ozemek et al., 2017).
This is one reason why workplace interventions and hypertension screenings could
significantly educate the masses on how best to reduce their risk of hypertension. Interventions
focusing on the best means of modifying one’s physical activity, dietary intake, increase weight
loss, decrease alcohol-drinking and smoking habits have been found to establish greater efficacy
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in reducing hypertension risk factors, like high blood pressure, compared with providing
guideline recommendations based on national guidelines (Ozemek et al., 2017). Alone, more
significant reductions in blood pressure can be achieved through specially designed programs
that provide various contact times with exercise, nutrition, and wellness professionals (Ozemek
et al., 2017). Ozmek et al. (2017), therefore, agreed that the most important means of improving
nutritional intake and decreasing negative lifestyle factors is through patient education. Most of
the studies into the dietary intake factors associated with hypertension also call for increased
physical exercise (Maldonado-Martin et al., 2016).
There has been a plethora of reliable evidence indicating that performing moderate-tovigorous physical activity, particularly aerobic exercise, and improving cardiorespiratory fitness
has a significant impact on reducing blood pressure levels and lowering the incidence of
hypertension (Bakker et al., 2018). Although evidence on this topic is limited to primarily
military-aged individuals and Baby Boomer populations, those studies that have been conducted
suggest that performing resistance exercise or improving muscular strength appears to be
associated with a lower incidence of hypertension (Zhou et al., 2017). It has been found that by
reducing sedentary time or replacing sedentary time with physical activity, an individual can
lower their blood pressure without medical intervention (Bakker et al., 2018).
To lower the risk of hypertension, healthcare providers must promote physical activity
and improve the daily fitness routines of at-risk patients, especially those at risk of
cardiovascular and cardiorespiratory disorders (Bakker et al., 2018). What can be agreed from
almost all the literature identified concerning physical activity and hypertension is that physical
activity is inherently linked to positive outcomes (Gambardella et al., 2020). However, more
research is needed to determine the effects of long-term sedentary behavior, resistance exercise,
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and muscle strength on the development of hypertension across diverse populations and settings,
suggesting that this is a limited area of understanding (Zhou et al., 2017).
Synthesis and Summary
Overall, it is clear from this review that this study aims to overcome and implement a
blood pressure screening program for adults in the workplace and occupational setting. One of
the common barriers to diagnosing and treating elevated blood pressure and undiagnosed stage 1
hypertension is the lack of knowledge of the disease and its long-term effects and adequate
educational resources to guide care. The failure to understand hypertension reduces the perceived
severity and susceptibility of the disease, reducing the chances of individuals taking action to
prevent and manage the disease. Research has suggested the importance of patient education,
which can increase the awareness of a person's increased risks for developing hypertension,
causing a change in self-care and disease management (Larki, Tahmasebi, and Reisi (2018). This
theory is called the Health Belief Model (HBM), which will be discussed in detail in the
theoretical framework section of this paper. By implementing a workplace screening protocol,
most members of the working population will be exposed to screenings. Increased exposure to
health screenings could allow for a diagnosis and a foundation of information on treatment
options.
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Needs Assessment and Description of Project
Population Identification
From this review of relevant literature, elevated blood pressure and hypertension is not
limited to a single demographic or group within the macro-population of the United States.
However, for this DNP project, the target population is the workforce aged 18 to 65, the average
age of the workers in the United States. These individuals do not fall into the subcategories of
children or older adults, who both respond differently to hypertension-related medical
interventions. The participants in this DNP project will meet the current guidelines for blood
pressure screening with a focus on identifying employees with elevated blood pressure and
undiagnosed hypertension stage 1. It is hoped that this DNP project will shed light on how to
macro-implement interventions for all types of individuals. As there are many demographic
variables within the traditional American workplace, the workplace intervention program must
be designed to be all-inclusive.
Identification of the Project Sponsor and Key Stakeholders
To complete this DNP project, other key stakeholders such as nurse practitioners (NPs),
physician’s assistants (PAs), medical assistants (MAs), and all other occupational medicine staff
will receive an updated review on AHA/ACC hypertension guidelines. As discussed in chapter
four, educational materials, program guidelines, and documentation requirements will be
provided to all stakeholders. One key stakeholder is the medical director. He has encouraged
completing this project due to the current need for multiple screening programs. Many
employees are removed from work due to uncontrolled hypertension. Taking employees off
work for uncontrolled hypertension can cause undesirable effects on the organization and to the
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employee. The president and vice president of the organization are also critical stakeholders as
this project could have positive benefits for employees and organizational leaders.
Description and Scope of the Project
The study was completed in four steps, and each participant completed a 30-day blood pressure
screening program:
1. All participating medical staff received training on the hypertension program guidelines,
equipment, patient education to be administered, and project timeline. Program education
and procedures were completed 30 days before the hypertension screening program/DNP
Project start date.
2. The recruiting phase began by monitoring the manual blood pressures of employees who
presented to the clinic for prescheduled visits. We identified potential participants by
screening for blood pressure readings greater than 120/80 mm Hg. The recruiting phase
was completed on an ongoing basis for 30 days.
3. Employees who met the program enrollment criteria and agreed to informed consent were
enrolled in the blood pressure screening program. Participants completed a baseline
Hypertension Evaluation of Lifestyle and Management Scale (HELMS) assessment
during this step, followed by hypertension and self-management education. Participants
were provided with a HBPM device with observed return demonstration education and
were provided a blood pressure monitoring sheet and asked to document their blood
pressures at home for two weeks.
4. The final phase of the blood project included a 30- day follow-up screening. Participants
returned their blood pressure monitoring sheet and received a review of their 2-week
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blood pressure measurements, additional hypertension prevention/management
education, completed a post (HELMS) assessment, and were informed of the completion
of the study. Documents were collected by the Project Coordinator and delivered to a
secured location on the UNLV Campus.
Cost and Benefit Analysis
Occupational medicine's annual budget provided financial resources to complete this
project. Automated blood pressure machines were priced at $35.00 each, 50 devices were
ordered, and 20 large blood pressure cuffs at $14.00 were purchased and received for the project.
Materials for participant education were provided by occupational medicine and approved by the
clinic's medical director. The total cost for the automated blood pressure machines is $1,750.00,
and blood pressure cuffs were a cost of $280.00 for a total cost of $2,030.00. This project was
supported by senior leadership, and all expenses were covered with no expected reimbursement
by participants.
Mission, Goals, and Objective Statements
Mission
The mission of this DNP project was to successfully implement a blood pressure
screening program within the workplace/occupational setting. By utilizing evidence-based
practice guidelines to screen participants for elevated blood pressure and undiagnosed stage 1
hypertension. With an intent to increase blood pressure control using the Health Belief Model to
provide patient-centered education, promote hypertension screening, improve self-management
and foster behavioral modifications.
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Goals
The goals of this DNP project are to:
1. Determine if implementing a hypertension workplace screening program will assist in
identifying and treating elevated blood pressure and undiagnosed stage 1
hypertension.
2. Utilize HBPM to document and educate participants who present with elevated blood
pressure and stage 1 hypertension.
3. Provide patient education on lifestyle modifications utilizing AHA handouts on How
Can Physical Activity Become a Way of Life? Managing Blood Pressure with a
Heart-Healthy Diet and blood pressure pamphlets.
4. Provide participants with HBPM devices and education to aid in self-management,
self-monitoring, and blood pressure control.
5. Determine if the workplace blood pressure screening program can assist 50 % of
participants in achieving a blood pressure of less than 140/80 mm Hg.
6. Compare the pre/post HELM assessment scores to determine if providing education
will increase hypertension knowledge and management on at least 50% of the
participants.
Objective Statements
The objectives for this DNP project are to:
1. Provide a review and training of the hypertension screening program to all
individuals involved in the project administration 30 days before the project start
date.
26

2. Provide timely recruitment by screening each employee during their in-clinic
visits for elevated blood pressure and stage 1 hypertension with an ongoing
enrollment process for 30 days.
3. Administer a new HBPM device to each participant with a blood pressure
monitoring sheet and utilize HBPM and in-office blood pressures to aid in
educating individuals presenting with elevated blood pressure and stage 1
hypertension ranges.
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CHAPTER III
Theoretical Framework
The Health Belief Model (HBM) will function as the theoretical framework for the
present study. Social psychologists Hochbaum and Rosenstock utilized Watson's 1925 StimulusResponse Theory and Lewin's (1951); Tolman, (1932) Cognitive Theory; and Skinner’s (1938)
hypothesis of behavior reinforcement to further develop the HBM in the 1950s to represent the
psychological processes that support or interfere with a person’s participation in healthpromoting behaviors and services (Abraham & Sheeran, 2007; Glanz, Rimer, & Viswanath,
2008). Generally, the model’s precepts include that a person’s perceptions of a particular health
concern interact with personal circumstances relative to the health concern to produce a higher or
lower likelihood of taking action to address the concern (Neff & Crawford, 2010). The primary
components of the model are perceived severity, perceived susceptibility, perceived benefits,
perceived barriers, and cues to action (Abraham & Sheeran, 2007). HBM has been widely used
to evaluate intent to carry out health-promoting behaviors based upon perceptions associated
with a particular health issue (Abraham & Sheeran, 2007).
Perceived severity refers to the seriousness of risk a person believes a health condition to
present, perceived susceptibility refers to the level of personal risk individuals believe
themselves to experience regarding the health conditions, perceived benefits refers to how
helpful seeking medical assessment or care for a condition might be, and perceived barriers
include obstacles to seeking care (Neff & Crawford, 2010; Abraham & Sheeran, 2007). Cues to
action are events or conditions that might trigger a person to seek assessment or care for a
condition. Researchers added self-efficacy, or individuals' appraisals of their capacity to carry out
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behavior change regarding the medical condition (Abraham & Sheeran, 2007). See Figure 1 for
an image of the HBM framework.

Figure 1 Health Belief Model Framework

From Critical Elements: Health Belief Model
By Sacred Heart University, N. Callaghan, S. Bieda, and
J. Centopanti, 2013 (https://midrangeborrowedtheory.wee
bly.com/critical-elements-health-belief-model.html) In the public domain.

The HBM model provides the rationale and strategy upon which the key stakeholders,
seeking to help the people living with hypertension manage their condition, can prioritize and
implement that identified action plan. Multiple studies suggested that patients receiving
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interventions utilizing the HBM had improved outcomes, increased patient follow-ups, and better
self-care compliance (Heydari, Kamran, Ahari, Biria, & Malepour (2014); Khalil & Tartour
(2017). Heydari et al. (2014) conducted a study involving 671 hypertensive patients and found
that the prevalence of adherence was 24% in the study population. Respondents with regular
physical activity and nonsmokers were more adherent to hypertension medication when
compared to respondents with a sedentary lifestyle and smoking. Based on HBM constructs, the
respondents who perceived high susceptibility, severity, and benefit had better adherence than
moderate and low susceptibility, severity, and benefit.
Research revealed that patients with more perceived susceptibility and perceived barriers
had a more significant influence on lifestyle modification recommendations, including diet,
smoking behavior, medication adherence, and blood pressure control (Larki, Tahmasebi, and
Reisi (2018); & Mirhoseini, Mazloomy, Moqaddasi, & Alizadehn, 2019). Since there is a
significant relationship between perceived barriers and hypertension, it is suggested that future
interventions be designed to reduce perceived barriers.
The Hypertension Evaluation of Lifestyle and Management Scale (HELM) assessment
was utilized in this DNP project to aid in implementing the HBM by evaluating the participants'
perceived severity and susceptibility to elevated blood pressure undiagnosed stage 1
hypertension. Understanding the participants' perceived severity and susceptibility could alert the
provider of the participants' knowledge level of elevated blood pressure and hypertension and
can aid in identifying barriers (Larki, Tahmasebi, and Reisi (2018). The goal of utilizing the
HELM assessment in this DNP project was to allow the medical providers to have increased
knowledge of what education was needed to present to the participants and assist in setting goals
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to encourage participation in the management and self-care of elevated blood pressure and
undiagnosed stage 1 hypertension.
Nöthling and Kagee (2013) posited that the HBM could be used to state that an individual
remains likely to undertake a health-related behavior and action only when they remain well
informed that the condition stands as controllable and manageable from a self-care view.
This DNP project is concerned with the efficacy of implementing a blood pressure screening
program for adults ages 18 - 65 in the workplace/occupational setting in reducing blood pressure
in people diagnosed with hypertension. Because this DNP project focused on the effects of
multiple psychological processes upon a specific health condition, hypertension, the HBM was
an appropriate framework for inquiry.
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CHAPTER IV
This Chapter will provide the methods and data analysis plan for the project. A
discussion of the setting, population of interest, and sampling technique are provided. Detailed
information regarding the measurements, instruments, and activities will then follow. The
timeline, project tasks, and resources will be discussed, including any anticipation of risks and
threats. This chapter will end with a discussion of the evaluation plan for the project.
Project Plan
Setting
This DNP project was completed at the employer’s work site in the Greater Clark County
area in the North Las Vegas Occupational Medicine Clinic. This worksite was chosen because of
the lack of screening programs and a significant need for a hypertension screening program. The
medical director discussed the need for a hypertension screening program as hypertension can
prevent some employees from working due to job requirements. The workplace has over 1,000
employees, some working in town and many in remote areas. The occupational clinic in North
Las Vegas intakes about 15 patients a day, four days a week, 60-80 patients weekly, which is
around 160 – 240 patients a month. Utilizing in-office recruitment, the PC attempted to recruit
50 participants. There was a significant decrease in patient volume due to the COVID-19
Pandemic. The clinic continued to complete physicals utilizing safety protocols and social
distancing to essential employees, as all non-essential employees were required to work from
home. We attempted to recruit one to two participants a day for four days a week to complete
this project based on our recruitment goal. The attrition rate was managed by requiring
participants to have a maximum of two appointments. Appointments occurred during working
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hours, were approved by management, and had no effect on pay. Participants were allowed to
schedule their appointment during a time that would not interfere with their work schedule. All
participants were rescheduled within 24 hours of the missed appointment.
Population of Interest.
The population of interest was adults ages 18 - 65 with undiagnosed elevated blood
pressure and hypertension stage 1. Employees who presented during their in-clinic visit with a
manual blood pressure between 120/80 mm Hg to 129/80 mm Hg (elevated blood pressure) and
130/80 mm Hg to 139/89 mm Hg (undiagnosed stage 1 hypertension) were of interest. This
project included adults with type II diabetes, a BMI >30, a history of smoking or currently
smoking/vaping/chewing tobacco, and hyperlipidemia. Participants with stage 2 hypertension or
higher and on blood pressure medications were excluded in this project due to increased
cardiovascular risks and to avoid conflict of assessment and treatment by their PCP. Also, all
participants diagnosed with end-stage renal disease, pregnant and women pregnant within the
last 12 months were excluded.
Measures, Instruments, and Activities
All participants were recruited during their in-clinic annual evaluations and on follow-up
visits. The PC was notified if the blood pressure was elevated during their appointment. If the
employees' blood pressure was in the elevated or stage I hypertension range, the participant was
informed of the study, given the opportunity to volunteer, and agreed to participate by signing
the informed consent. The PC was not permitted to recruit by any other means per the company’s
legal department's directions.
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Participants were notified that this DNP project will not affect their current job position.
Participants were enrolled on an ongoing basis. All new employees were monitored, and if
criteria were met, they were enrolled in the program if they consented to participate. There was
no discipline for failure to participate.
The HELM assessment is a reliable and validated questionnaire (Schapira et al., 2012).
This assessment was utilized to assess the patient’s hypertension knowledge and selfmanagement during the pre/post-program completion. The HELM assessment is a 17-item
questionnaire that includes 3 domains: general hypertension knowledge, lifestyle and medication
management, and measurement and treatment goals (Schapira et al., 2012). Schapira et al. (2012)
completed a study utilizing the HELM assessment, which was determined to be a practical tool
to determine if participants obtained the knowledge needed to be an active participant in the selfmanagement of hypertension. Participants were administered the HELM assessment on day one
of the screening program and again after 30 days to measure the effectiveness of patient
education and reassess the participants' perceived severity and susceptibility to elevated blood
pressure and stage 1 hypertension. Reviewing the HELM assessment allowed the providers to
assess for educational deficits and barriers and assess if patient education cued the participant to
recommended actions, such as lifestyle modifications, as the HBM suggests.
Blood pressures were measured in the clinic manually using a stethoscope and
appropriate size brachial pressure cuff with a sphygmomanometer. The equipment was calibrated
daily to ensure accuracy. The Digital Blood Pressure Monitoring Unit Drive upper arm models
were utilized for the home self-monitoring of blood pressures. As previously mentioned, the
blood pressure device was by occupational medicine and is equipped with easy-to-use function
buttons on the front. Larger font/button machines were purchased for individuals with difficulty
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reading or needing larger buttons to press. Fifty blood pressure machines were purchased, and
the company gave permission to buy more machines if required. The World Health Organization
(WHO) Blood Pressure Classification Indicators are on each device. The WHO classification
levels are indicated by green, yellow, orange, and red. Green ranges from optimal, normal, and
high normal hypertension; yellow: mild hypertension, orange: moderate hypertension, and red:
severe hypertension. The blood pressure machine includes an irregular heartbeat indicator. A
heart symbol will appear if an irregular heartbeat occurs twice during any reading.
The participants' initial blood pressure documented from their clinic visit was utilized as
their baseline blood pressure if greater than 120/80 mm Hg. These participants were then
provided program details, signed the informed consent, and continued with the program.
Participants then received a second manual blood pressure reading. They continued the study if
their blood pressure remained above 120/80 mm Hg. The staff waited five minutes before
repeating the blood pressure and recorded the second reading as the final blood pressure for all
participants. Each participant then completed a pre-HELM assessment patient education session,
then tasked with completing twice a day HBPM for two weeks. Specifically, HBPM devices
were provided to all the participants. For two weeks, they were instructed to take their blood
pressure twice a day (one in the morning before they eat or drink and one in the evening before
eating or drinking). They were then scheduled for a follow-up at the occupational medicine clinic
in 30-days for the NPs/PAs to repeat an in-office blood pressure measurement and review the
participants’ HBPM sheet. The participants received additional patient education at their followup visits if their blood pressure levels were still elevated, they requested more information, or the
provider determined there to be a knowledge deficit. The following defined if participants
received additional education. If they did not implement the lifestyle modification
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recommendations in their routine, they verbalized the need for physical activity or specific diet
education. HBPM results were reviewed, and any additional education or recommendations were
provided. More details concerning the project are listed below in the project plan section of this
paper.
HBPM was chosen for this project because the occupational medicine clinic has utilized
walk-in blood pressure screenings with no success in the past. On many occasions, elevated
blood pressures were documented on patients who visited the clinic for a blood pressure check,
with no follow-up or appropriate education given. Research suggests that having one blood
pressure is not efficient enough for a diagnosis due to the many factors that contribute to the
elevation of the blood pressure (Pioli, Ritter, de Faria, & Modolo, 2018). So, HBPM is strongly
recommended; it gives an accurate picture of an individual's blood pressure at home or in
different settings. Having multiple blood pressure readings could aid providers in diagnosing and
treating elevated blood pressure and hypertension. Other blood pressure screening options were
not utilized in this project due to the cost of devices and barriers that would interfere with
screening, such as time and patient compliance.
Timeline
The project proposal began in January 2020. The project started September 2021 after
Institutional Review Board (IRB) approval was obtained during the Fall semester of 2021 from
the University of Nevada Las Vegas (UNLV) and the students’ worksite. The project was
delayed due to the students’ worksite legal department requiring multiple changes to the project.
The IRB board was also delayed related to the Covid-19 Pandemic. Data collection, analysis, and
review occurred during the Spring semester of 2022. Before completing the Spring 2022
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semester, the DNP project was completed and approved by all committee members, followed by
the defense of the project.
Project Tasks and Personnel
The personnel for this project were NPs, PAs and MAs. The project tasks were completed
in 4 phases.
Phase 1
1) NPs/PAs received education 30 days before the program start date, including a
refresher training on the AHA/ACC hypertension guidelines listed below:
a. Weight optimization, heart-healthy diet, sodium restriction, physical activity with
a structured exercise program, abstinence from or moderation of alcohol
consumption, and smoking cessation (Sharma et al., 2019).
b. The term prehypertension has been replaced with elevated blood pressure
(Sharma et al., 2019).
c. Elevated blood pressure is ranged from 120-129/80-89mm Hg, and stage 1
hypertension is greater than or equal to 130-139/80-89 mm Hg (Sharma et al.,
2019).
d. NPs/PAs, and MAs received all education materials that were to be provided to
participants.
i.

How Can Physical Activity Become a Way of Life? (Appendix D.)

ii.

Managing Blood Pressure with a Heart-Healthy Diet (Appendix E.)

iii.

What is High Blood Pressure? (Appendix F.)

iv.

Blood Pressure Monitoring Sheet (Appendix G.)
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v.

Hypertension Evaluation of Lifestyle and Management Scale (HELM)
(Appendix H.)

e. All program materials were labeled workplace blood pressure program and filed
in a red folder placed in the medical records room labeled workplace blood
pressure program by the participating team members.
f. Participants who failed to follow up for an appointment were contacted by phone
to reschedule within 24 hours of their missed appointment.
Phase 2
2) The recruitment process involved enrolling participants on an ongoing basis.
a. Employees were recruited at their in-clinic evaluations for annual screenings
and follow-up visits.
b. The MA’s or Providers would then notify the SI about any employee with
elevated blood pressure.
3) Identified potential participants were then asked to voluntarily participate in the
Hypertension Screening Program. They were provided details about the program and
notified that this project would not affect their job position. All identified individuals
were recruited and enrolled in the program ongoing basis if they agreed to participate
and completed the informed consent. Participants were notified that they could stop
participating at any time and were not mandated to complete the study. Due to the
COVID-19 Pandemic, there were increased risks of contacting Covid-19 in
public/private settings. To decrease these risks, we followed CDC guidelines to
include: (a) completing an online Covid-19 screening sheet before being permitted
onsite, (b) asking all participants to stay home if sick and to report any new Covid-19
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symptoms to occupational medicine, (c) social distancing at all times while on-site,
(d) wearing face coverings/face masks at all times while on-site and in the
occupational medicine clinic, (e) completing a Covid-19 screening questionnaire
while in the occupational medicine clinic, (f) recommending frequent hand washing.
We provided multiple hand hygiene stations throughout the worksite and
occupational medicine clinic. At no cost, the Moderna vaccine was offered to all
employees to help prevent/reduce the spread of Covid-19, and all occupational
medicine providers were fully vaccinated. All occupational medicine providers wore
N-95 masks during patient encounters for this project for the safety of the participants
and staff. The participants were exposed to staff for less than 5 minutes during blood
pressure collection. Patient education, administration of the informed consent,
HELMS questionnaire, review of home blood pressure sheets, and referral occurred
in a patient room. The provider and participant were more than 6 feet apart
throughout the visit.
Phase 3
4) Blood pressure screenings were conducted by MAs trained in manual blood pressure
measurement. NPs/PAs trained in manual blood pressure measurement completed
blood pressure measurements if needed and during staff shortages. Participants who
agreed to participate with elevated blood pressure or stage 1 blood pressure reading
during their in-clinic visit completed the following steps on day 1 of the program: (a)
signed informed consent before participation, (b) had their second blood pressure
measured, and (c) completed a pre-HELM assessment reviewed by the NP/PA.
Participants who had a blood pressure of less than 120/80 mm Hg during their second
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blood pressure measurement were notified they no longer qualify for the study. The
post-HELM assessment was administered for comparison during the participants' 30day evaluation. Blood pressures were collected in the North Las Vegas clinic after a
5-minute resting interval to improve the accuracy of the blood pressure. If
participants had an SBP greater than 120-139 and DBP greater than 80-89 mm Hg,
they required a repeat blood pressure.
5) Day 1 of the program was defined as the day each participant had their first elevated
blood pressure reading documented. On day 1 of the program, if the participant's
blood pressure was higher than 120/80 mm Hg. The MAs then notified the PC of the
elevated blood pressure. The PC then went and evaluated the employee, collected a
medical history and medication review, informed the employee of the study, and
asked them to voluntarily participate. If the employee agreed, they were consented
and started the program immediately. The MA then repeated the blood pressure and,
if elevated, waited for 5 minutes, repeated the blood pressure again, and documented
the last blood pressure as the second blood pressure reading. If the participant's blood
pressure remained higher than 120/80 mm Hg, they were informed to continue in the
program. If the participant's blood pressure was less than 120/80 mm Hg, they
remained in the room. A provider was notified to discuss the results and informed the
participant that they were not continuing in the program as their blood pressure had
normalized. However, we still provided lifestyle modification education to educate
about disease prevention. If the patient had blood pressure between 120/80-139/89
mm Hg, the provider gave thorough patient education, followed the AHA/ACC
hypertension treatment guidelines, and followed the steps below:
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a. Provided lifestyle modification education. This education included
hypertension education resources from the AHA on How Can Physical
Activity Become a Way of Life? (Appendix D.), Managing Blood Pressure
with a Heart-Healthy Diet (Appendix E.), and “What is High Blood Pressure”
(Appendix F.).
b. Offered an in-depth discussion on hypertension and prevention and set
individualized goals. All participants were given resources to our wellness
center that provides free/discounted activities, including health education
sessions, cooking classes, exercise resources, and other benefits.
c. All participants were referred to their PCP for disease monitoring and other
preventive health screenings.
d. Participants were notified of their follow-up to include:
i.

30-day follow-up appointment for blood pressure reassessment,
HBPM review, post-HELM assessment completion, repeat blood
pressure, provided average blood pressure reading, final participant
education session, and notification program completion.

e. All records were reviewed by the PC on an ongoing basis until program
completion and temporarily stored in a locked medical records office on the
work site.
6) After the participant education session, all participants received a Digital Blood
Pressure Monitoring Unit Drive upper arm monitoring device and a blood pressure
monitoring sheet to document their blood pressure.
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a. Participants were educated on the use of the blood pressure machines and cuff
placement using the recommended instructions that come with the device.
Each Participant was monitored providing a return demonstration on the use
of the upper arm unit. This was completed to ensure they used the machine
correctly and identified early problems handling the device.
b. The NPs, PAs, and MAs received education on battery replacement, alarm
settings, and replacement cuffs.
c. Participants were advised to read all safety notices regarding testing
guidelines, unit operation, machine maintenance, and low battery indicator
information before use.
d. The participants were allowed to keep the blood pressure cuffs/devices at the
end of the self-home monitoring trial.
e. Participants were advised if the blood pressure machine's irregular heartbeat
indicator alarms frequently to consult with their PCP and notify occupational
medicine for further assessment.
7) Participants were instructed to monitor their blood pressure twice daily, once in the
morning and once at night at the same time every day if possible. The blood pressure
monitoring sheet included the date, time, SBP/DBP readings, and participants
recorded data for two weeks (Appendix G.). The blood pressure monitoring sheet
included instructions reminding participants to (a) sit in a calm area five minutes
before blood pressure reading, (b) avoid talking or eating, or excessive physical
activity 30 minutes prior or while monitoring blood pressure, (c) if blood pressure is
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higher than 120/80 mm Hg to wait 1-2 minutes before repeating blood pressure, (d)
measure their blood pressure with the arm in a position that is leveled to the heart.
8) Participants with multiple blood pressures greater than 140/90 mm Hg without any
signs or symptoms were recommended to see their PCP or urgent care provider as
soon as possible and explained the risks of prolonged hypertension. On multiple
readings, any participant with severe hypertension or blood pressure greater than
180/110 mm Hg was advised to follow up with their PCP, urgent care, or emergency
department for immediate evaluation and treatment if at home.
a. Emergency medical services would be notified if severe hypertension
occurred in the clinic. The participant would be referred to the emergency
room for immediate treatment.
b. Suppose participants refused to seek treatment for stage 2 hypertension or
higher. In that case, they would be given an Against Medical Advice Form
(AMA) to sign and informed of all risks but will not continue in the program.
9) Participants were instructed to bring their blood pressure monitoring sheet during
their scheduled 30-day follow-up to be reviewed by NPs and PAs for blood pressure
education and data collection purposes. Participants were scheduled and seen by a
provider on day 1 of the program and for a 30-day follow for a total of 2 visits.
Phase 4
a.

Participants returned for their 30-day follow-up, which was their final visit.
The last blood pressure was collected and recorded, and the HBPM
monitoring sheet was reviewed. Each Participant was informed of their 2week average blood pressure range and provided additional education on
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blood pressure management if requested. No diagnosis was provided during
this project. Participants were encouraged to continue the lifestyle
modification changes and periodic blood pressure monitoring. They were
informed to follow up with their PCP or establish care with a PCP for
continuity of care.
b. All paper documents were scanned into a secure google drive account, where
they were pulled from the drive and stored on the PI’s secured drive. All files
were then deleted from google drive. All paper documents were securely
transported weekly to the PI’s office on UNLV Campus and stored in a locked
file cabinet.

Resources and Supports
The worksite provided printers, printer paper, computers, email, telephones, blood
pressure devices, and other resources. The worksite medical director supported this project and
was a constant resource if needed, while also providing a reasonable budget to complete this
DNP project. This DNP project was supported by occupational medicine staff and senior
leadership.
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Risks and Threats
The ethical aspects of this project were privacy, confidentiality, and respect for all
participating individuals. The project was designed to impose no risk to all participating
individuals. The privacy of the staff and participants were fulfilled by only allowing the PC and
the PI to view participants’ identifier information. Participants names were not included in the
collection data; therefore, the confidentiality and privacy of the participants were maintained.
The process of preserving privacy and confidentiality was maintained by ensuring nonidentifiable forms were provided and participants were educated on using their unique identifier
number if they needed to contact the PC or PI.
The SI adhered to privacy, confidentiality, and legal rights using the Health Insurance
Portability and Accountability Act (HIPAA) regulations to protect the participants' rights. The
PC has the duty and responsibility to maintain the HIPAA regulations, followed by the
institution at the project site. The PC did not disclose any patient information to inside project
site employees and outside societal beings. Any information collected, such as hard copies of
data from the project site that requires privacy and confidentiality protection, is securely stored.
All data will be kept for three years; the information will be stored in a secured locked location
in the PI’s office on the UNLV campus. An IRB approval was requested and granted effective on
September 16, 2021.
Evaluation Plan
To evaluate the efficacy of the implemented blood pressure screening program for adults
in the workplace, the compiled data collected will help determine that:
(a) 100% of the participants receive a HBPM device and understand how to properly measure
their blood pressures at home.
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(b) 100% of the participants receive patient education on lifestyle modification including
handouts
(c) 100% of the participants receive blood pressure monitoring sheets (Appendix G.)
(e) Blood pressure levels will be examined in all participants to determine if there is any impact
on their blood pressure values after the program completion to have 50% of individuals remain
less than 140/80 mm Hg.
(f) The HELM assessment scores will be evaluated for effectiveness of hypertension and selfmanagement education using the participants’ pre and post score results with 50% of participants
having improved hypertension knowledge.
Evaluating the items listed above will help determine if the program was effective and provide
useful information for future observations.
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CHAPTER V
Summary of Implementation and Results
This DNP project evaluated a blood pressure screening program in the
occupational/workplace setting to reduce hypertension, increase hypertension knowledge, and to
improve the management of undiagnosed elevated blood pressure and hypertension stage 1. We
administrated evidenced based education regarding hypertension, diet, exercise, and healthy
weight loss to participants and each participant received a HBPM device to measure their blood
pressures at home for two weeks. A pre and post HELMs assessment was completed to assess
participants’ hypertension knowledge. Participants were recruited during employee visits to the
clinic. Data collection occurred during participants first visit (pre-intervention) and at their 30day follow-up appointment (post intervention), which was their last visit.
Precis of the Phenomenon of Interest and the Problem and Purpose of the Project
The phenomenon of interest was addressing hypertension in the workplace. Many
working people have hypertension and the inability to recognize symptoms can increase the risk
of cardiovascular disease and cause multiple systemic health concerns. Late screening and
diagnosing of hypertension can increase the risk of cardiovascular disease, which can lead to
death (Seibt et al., 2018). Therefore, the purpose of this project was to determine if the
implementation of a workplace blood pressure screening program; by screening blood pressures,
assessing hypertension knowledge, providing patient specific education, and utilizing home
blood pressure monitoring would guide care, promote self-management, and improve
hypertension knowledge.
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Threats and Barriers to the Project
There were multiple threats and barriers to this project such as the PCs legal workplace
restrictions, time constraints, and employee/participant engagement. The legal department would
only allow up to two patient visits to prevent workplace productivity concerns. The Covid-19
Pandemic was a major barrier as this caused multiple delays with the IRB and delayed the
implementation of my project by almost two semesters. Covid-19 caused multiple participants to
withdraw from the study due to illness. The timing of the project during the major holidays
caused concerns for potential participants, which prevented participation as they felt they would
not be able to commit to the study’s criteria.
A significant threat to the project was the sample size as the goal of the study was to
recruit at least fifty participants; however, due to loss of follow-up at 30 days, our sample was
less than anticipated despite extending by a few days to allow for the completion of the 30-day
follow up. Many participants needed additional reminders to complete the study and to complete
the HELM questions. The HELM instrument was lengthy, and many participants thought the
questions were difficult to answer, which increased the length of time to complete the
assessment. Therefore, the participants were reminded to go with their first choice and not to
overthink the assessment. The concerns regarding the length of this project and the difficulty in
questions have been noted by developers of the HELM instrument (Schapira et al., 2012).
Another threat was the number of participants whose blood pressure was within normal range
after the first elevated blood pressure reading at the clinic, which accounted for (0.5%) of
participants who were no longer eligible to participate in the study. Another threat of this study
was the inability to follow-up with participants during the study, which could have been the
reason some participants failed to complete the study.
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Monitoring of the Project
The HELM hypertension instrument was obtained from public domain and used for
educational purposes and no permission to use this instrument was required. All educational
materials used in this DNP project was evidenced-based and were submitted to the PCs
committee and approved by UNLV’s IRB. The project initiated once UNLV’s IRB granted
approval. All NPs and MAs who volunteered to assist with the study received education on
recruitment and the study protocol 30 days prior the start of the study. Education was provided to
the providers and staff prior to ensure they were up to date on the latest hypertension guidelines.
Of concerns, many staff members would fail to document elevated blood pressure as abnormal.
Only the PC was involved in the consenting process. Participants received an identifier number
with materials to maintain confidentiality and only the PC and PI had access to consents or any
identifying information. All de-identified data was transferred to an excel sheet, shared with a
committee member who assisted with the data analyses, and then shared with the biostatistician
for additional analysis/interpretations. The PC and PI monitored every element of this project
through all stages with no reported concerns.
Data Collection and Data Analysis
A total of 33 participants completed the intervention, having their blood pressure
measured pre and post. Additionally, pre and post-HELMS scores were recorded. Ages of
participants ranged from 25 to 60 years of age (M = 39.12, SD = 10.40). There were 16 (48.5%)
females and 17 (51.5%) males. Regarding ethnicity, most were Hispanic, 13 (39.4%). This was
followed by White, 10 (30.3%); Asian, 9 (27.3%); and Black, 1 (3.0%). See table 1.
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Table 1 Demographic Characteristics (N=33)
Variables

freq (%)

Age
25-60

M = 39.12, SD = 10.40

Female

17 (51.5)

Race/Ethnicity
White

10 (30.3)

Asian/Pacific Islander

9 (27.3)

Hispanic/Latino

13 (39.4)

Black or African-American
Total

1 (3.0)
33 (100)

There was a reduction in SBP and DBP from pre (M = 127.30, SD = 4.83)
to post-intervention (M = 125.42, SD = 8.39) SBP, pre (M = 80.06, SD = 4.48)
to post-intervention DBP (M = 77.58, SD = 7.21), respectively.
See Table 2 and Figure 2.

Table 2 Pre and Post-Intervention SBP & DBP Measures (N=33)

Systolic Pre
Systolic Post

N
33
33

M
127.30
125.42

SD
4.83
8.39

Diastolic Pre
Diastolic Post

33
33

80.06
77.58

4.48
7.21

Differences in Pre/Post Systolic and Diastolic Pressure by Gender, Age, and Race
Gender
Differences in pre/post intervention readings of SBP and DBP by gender were measured
(see Table 3). Females had a greater mean difference in both systolic (Mdiff = 3.44, SD = 6.85)
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and diastolic (Mdiff = 3.06, SD = 7.68) compared to male in systolic (Mdiff = 0.41, SD = 5.21) and
diastolic (Mdiff = 1.94, SD = 5.81).

Table 3 Differences in Pre/Post-Intervention SBP and DBP by Gender (N=33)
Gender

Female

Systolic
difference
Diastolic
difference
Systolic
difference
Diastolic
difference

Male

N
16

Minimum
-16.00

Maximum
17.00

M
3.44

SD
6.85

16

-13.00

13.00

3.06

7.68

17

-10.00

9.00

.41

5.21

17

-13.00

13.00

1.94

5.81

Age
Differences in systolic and diastolic blood pressure readings by age are depicted in the
scatter plots shown in Figures 2 and 3. The differences in diastolic pressure (from pre- to postintervention) seem to increase with age, on average as noted by the positive slope of the linear
regression line in Figure 2. While the differences in systolic blood pressure (from pre- to postintervention) seem to decrease with age, as denoted by the negative slope of the regression line
shown in Figure 3.
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Figure 2 Scatter Plot of Age Versus Diastolic Blood Pressure Differences from Pre to Post
Intervention (N=33)

Figure 3 Scatter Plot of Age versus Systolic Blood Pressure Differences from Pre to Post
Intervention (N=33)
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Race
Differences in systolic and diastolic blood pressure readings by race are depicted in Table
4. The greatest mean differences were shown in the Hispanic/Latino group (Systolic Mdiff = 3.62,
SD = 5.34; Diastolic Mdiff = 5.08, SD = 7.08). The least mean difference was in the Asian group
(Systolic Mdiff = 0.89, SD = 7.06; Diastolic Mdiff = -.33, SD = 5.00). Regarding White, systolic
mean difference was Mdiff = 1.10 (SD = 6.52) and diastolic was Mdiff = 3.20 (SD = 5.07). There
was one Black/African American individual that had an increase in both systolic (Mdiff = -4.00)
and diastolic (Mdiff = -13.00) blood pressure measures.

Table 4 Differences in Pre/Post-Intervention SBP and DBP by Race/Ethnicity (N=33)
Race
Asian

Systolic difference
Diastolic difference

N
9
9

M
.89
-.33

SD
7.06
5.00

Black/African American

Systolic difference
Diastolic difference

1
1

-4.00
-13.00

.
.

Hispanic/Latino

Systolic difference
Diastolic difference

13
13

3.62
5.08

5.35
7.08

White

Systolic difference
Diastolic difference

10
10

1.10
3.20

6.52
5.07
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Results of Paired t-Tests for SBP and DBP
A paired t-test was conducted with SPSS to determine if there was a significant change
from pre- to post-intervention in SBP and DBP. Mean pre-systolic pressure was M = 127.30 (SD
= 4.83). Mean post-systolic pressure was reduced to M = 125.42 (SD = 8.39). This mean
reduction of 1.88, 95% C.I. [-.305, 4.062], was not significant, t(32) = 1.753, p = .089. Mean prediastolic pressure was M = 80.06 (SD = 4.48). Mean post- diastolic pressure was reduced to M =
77.58 (SD = 7.21). This mean reduction of 2.49, 95% C.I. [1.09, 4.860], was statistically
significant, t(32) = 2.131, p = .041. See Tables 5 and 6.

Table 5 Paired Samples Test for SBP and DBP
Paired Differences
Mean Std.
Std.
Deviation Error
Mean

T

1.879 6.158

1.072

95% Confidence
Interval of the
Difference
Lower
Upper
-.305
4.062

Diastolic Pre -- 2.485 6.699
Diastolic Post

1.166

.109

Systolic Pre –
Systolic Post

4.860

1.753 32 .089

2.131 32 .041

Table 6 Paired Samples Statistics for DBP (N=33)

Diastolic Pre
Diastolic Post

N
33
33

M
80.06
77.58
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Df p

SD
4.479
7.211

Hypertension Evaluation of Lifestyle and Management Scale (HELMS) Assessment
Participants completed a baseline Hypertension Evaluation of Lifestyle and Management
Scale (HELMS) assessment pre- and post-intervention. There were 17 items on the HELMS and
were graded as the number of items correctly answered. As such, possible scores ranged from
zero to 17. There was a mean increase in the number of correct answers from pre (M = 10.27, SD
= 2.34) to post-intervention (M = 13.42, SD = 3.01). See table 7.

Table 7 Pre/Post-Intervention HELMS Scores (N=33)
N
33
33

Helms Pre Total Correct
Helms Post Total Correct

M
10.27
13.42

SD
2.34
3.01

Paired t-tests were conducted to determine if there were significant mean differences
from pre-post intervention in systolic pressure, diastolic pressure, and HELMS scores. However,
prior to conducting the tests, there were parametric assumptions that had to be tested. These
included normality of difference scores and absence of outliers. Regarding Normality, skewness
and kurtosis index were used to identify the normality of the data. The results suggested the data
was approximately normal, as skewness and kurtosis index values were between -2 to +2 and
kurtosis is between -7 to +7 (Hair et al., 2010; Bryne, 2010).
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Results of Paired t-Tests for HELMS Scores
A paired t-test was conducted determine if there was a significant change from pre- to
post-intervention in HELMS scores. Mean pre- HELMS score was M = 10.27 (SD = 2.34). Mean
post- HELMS score was increased to M = 13.42 (SD = 3.01). This mean increase of 3.15, 95%
C.I. [-4.14, -2.16], was significant, t(32) = 6.474, p < .001. See tables 8 and 9 p.

Table 8 Paired Samples Statistics

Helms Pre Total Correct
Helms Post Total Correct

M
10.27
13.42

N
33
33

SD
2.34
3.01

SE Mean
.41
.52

Table 9 Paired Samples Test

Helms Pre –
Helms Post

Paired Differences
M SD Std. Error 95% Confidence Interval
Mean
of the Difference
Lower
Upper
2.79 .49
-4.14
-2.15
3.15
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T

df p

32 .000
6.474

Giving Meaning to the Project
Discussion of the Results of the Project
Our DNP project found that systolic and diastolic blood pressure levels were reduced
after implementing educational tools. Future studies should focus on current guidelines,
recommendations of blood pressure screening, treatment recommendations, and hypertension
education. Additionally, HELMS scores increased on average after implementing the educational
materials, suggesting that knowledge regarding hypertension can increased after education was
introduced.
Discussion of the Degree to Which the Project Did or Did Not Address or Remediate the
Problem Identified
The problem identified earlier was that hypertension is a disease that many people suffer
from without noticeable signs and symptoms, which later can lead to significant CVD, renal
disease, and at its worse, death (Seibt et al., 2018). Fortunately, hypertension is a modifiable
disease, and screening in the workplace could increase early detection and disease management.
Additionally, screening for hypertension could provide early identification, treatment,
individualized patient education, and lifestyle modification. This project showed that the
reduction in DBP was indeed significant; however, the reduction in SBP was not significant.
Additionally, HELMS scores did significantly increase after the educational tool was
implemented.
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Discussion of the Relationships Among the Project Results to Evidence Identified in the
Review of the Literature and Theory Underlying the Project
The current project results indicated a significant reduction in diastolic blood pressure
after implementing the education tool Based on the project results, HELMS scores increased
after implementing an educational program, which in turn increase participants' hypertension
knowledge. The findings have several links to the literature review conducted in chapter two. In
this section, the current project results will be discussed concerning the existing literature on the
effectiveness of the educational intervention on educational management.
Current evidence indicated that education interventions of different time durations had
been used in several studies to improve participants' hypertensive knowledge and life
modification designed to lower their blood pressure. For instance, a monthly educational
program conducted over six months by Ozoemena et al. (2019) indicated considerable
improvement in medication adherence, lifestyle modification, and reduced blood pressure for
participants diagnosed with high blood pressure. Similar results were found in another study
conducted in eight weeks, educating patients with hypertension in a nursing home setting
(Solano Lopez, 2018). They found that patients who attended hypertensive educational sessions
over the eight weeks reported a 10% or the equivalent of 10 mm Hg reduction in their systolic
blood pressure compared to patients who did not attend educational sessions for hypertension
management (Solano Lopez, 2018).
Additionally, a randomized controlled trial study assessing the effect of weekly
educational programs for 11 weeks among patients with hypertension established that increasing
patients' knowledge about hypertension relating to exercise and lifestyle behaviors led to a
significant reduction in their systolic blood pressure by 5 mm Hg (Calano et al., 2019).
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Comparable results were found by Tavakoly et al. (2018), they found a 6 mm Hg reduction in
systolic blood pressure following 12 weeks of programs on hypertension management. Similarly,
Tan et al. (2019) found improvement patients' knowledge on managing and self-care
hypertension improved self-efficacy after 8-weeks of educational delivery. Furthermore,
Lauzière et al. (2013) established that providing hypertensive patients with education on how to
monitor, adjust their lifestyle, and adhere to medication led to improved hypertensive awareness
among patients’ positive outcomes on systolic/diastolic blood pressure. As well, Katende et al.
(2014) indicated that implementing an educational program designed to make patients aware of
lifestyle practices that could lower blood pressure improved their knowledge in hypertensive
self-care management. Among these participants, it was established that there was a reduction in
systolic and diastolic pressure after attending an educational program (Katende et al., 2014).
These studies supported that education programs on hypertension have promising results on
blood pressure reduction.
The above studies indicate that the project findings are consistent with current literature
on the effectiveness of educational intervention management. Similar to previous literature, the
current project findings demonstrate that attending educational programs on hypertension
management positively correlates to improved systolic and diastolic scores. Therefore, given the
current project results, it is concluded that educating patients about hypertension, its causes, and
self-care practices that can minimize its severity is critical to lowering their blood pressure.
Although this DNP project did not show a significant change in SBP’s, many factors can cause
the fluctuation of blood pressures and this project was limited to only provide two clinic visits in
a thirty-day timeframe. Significant change in the diastolic blood pressure, may be related to time
of day and/or lifestyle modification changes.
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Seibt et al., 2018 suggested that utilizing blood pressure screening programs in
occupational medicine with the use of HBPM can help identify individuals with hypertension
and allow for the timely treatment of hypertension. Their study also revealed that blood pressure
screening in the occupational workplace setting has been underestimated and findings supports
those individuals with increased physical work had increased blood pressure levels compared to
workers with mental workload or a mix of physical and mental workloads (Seibt et al., 2018).
For this reason, blood pressure screening in the workplace should not be taken lightly, since
many adults spend most of their lives in the workplace and many workplace stressors can induce
elevated blood pressure (Seibt et al., 2018).
Discussion of How the Project Advanced or Improved Nursing Practice or Patient Outcomes
Essential II: Organization and System Leadership for Quality Improvement and
System Thinking. This nursing essential aims to address the overall approach to system
improvement from a leadership perspective concerning modifying the current system is ideal, not
inventing a new system for triage. The project's site has recorded increased patient volume over
the years, due to increased work demands. There is a need for an improved approach towards
hypertension management and self-care worldwide. The current project was designed to improve
workplace screening practices, patients' hypertension knowledge and improve self-care
management of hypertension. In this project, this essential contributed to improved diastolic
scores after attending one educational session and improved hypertension knowledge. The
current findings have several implications for healthcare providers and other entities on how to
offer healthcare education. Educating patients on hypertension management and encouraging the
development of self-care goals positively impacted patients' knowledge of hypertension. By
implementing this project's intervention, healthcare providers may improve patients'
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hypertension self-care measures, potentially impacting their blood pressure control and risk of
morbidity.
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based
Practice (EBP): Essential III will achieve in this project following the interpretation of data
gathered to initiate the DNP project and how to apply the information collected as EBP for
continued improvement. The project addressed this essential using an educational project that
has been validated empirically to measure blood pressure and offer guidance to patients on how
to manage hypertension by utilizing AHA/ACC hypertension guidelines, which are evidencebased. Therefore, the current results contribute to the practice by providing healthcare providers
with valuable knowledge on managing hypertension. Nurses can use these findings to design and
implement supplementary educational programs to improve public and workplace knowledge
about hypertension and self-care management practices such as lifestyle, diet, and physical
exercise in managing hypertension. Patient outcomes also improved after implementing the
current project. In particular, the project findings indicated a positive change in diastolic scores
after implementing an educational program for hypertension. Therefore, the current project could
significantly impact patient outcomes, including improved health, and self-care management.
Potential for Sustainability
The implementation process for this DNP project has helped healthcare providers to
identify the significance of education on hypertension management such as physical exercise,
medication adherence, nutrition and dietary needs, and other self-care practices. This knowledge
related to the above factors is critical in ensuring that patients understand the best practices for
the self-management of hypertension, which can aid in minimizing unnecessary hospitalizations.
Data collected from this project could be used to inform healthcare guideline developers and
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further interventions at both local and international levels by incorporating information and
resources found in the AHA/ACC guidelines. The fundamental to the sustainability of this
project is embedding educational interventions in all aspects of hypertension management from
screening, diagnosis, and treatment with all clinical appointments. The screening tool and
education interventions can be implemented during a patient interview with clinical staff and
throughout the patient visit; however, the importance of hypertension screening must be
recognized. The current project findings will ensure hypertension screenings are expanded and
monitored to continuously assess the effectiveness of the hypertension program and to provide
evidence-based education to patients on self-care management practices for hypertension to
reduce systolic and diastolic pressure in the workplace.
The project results indicate that educational intervention improves blood pressure.
Therefore, there is a need to underscore sustainable change by ensuring that brochures on the
intervention are available to the within the workplace, which could benefit the public and/or
family members of employees. This positive change may be replicated within the entire
community. The patient's educational brochure on the educational intervention for hypertension
may be distributed to different health facilities and gatherings among different groups to help
promote positive health behavior and outcomes among the community, mainly due to the costeffectiveness of the current project. The findings on brochures on the current intervention may
also be distributed to other populations in the primary care setting to improve healthcare
outcomes and decrease the overall cost of managing and controlling hypertension such as
cardiovascular complications.
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Utilization and Dissemination of the Results
Future Scholarly Activities Resulting from this Project
The current project was conducted in less than six weeks and produced short-term
findings. Given this time limitation, it is recommended that further research be undertaken to
determine longer time impacts of hypertension education lifestyle behavior as this evidencebased intervention has the potential to catalyze positive health behaviors in the community.
Given the current findings, it is recommended to provide well-designed educational
programs that are interactive and grounded in theory to the needs of hypertensive patients to
improve the management of blood pressure. Further research is also needed to replicate the
current findings in other settings. This could include using other populations such as the elderly
and the youth and determining the effectiveness of hypertensive educational intervention
programs on blood pressure across genders.
Future studies may incorporate the current programs, interventions, and tools to examine
the effects of an education intervention on blood pressure self-care management practices using a
large sample over an extended period to include other pertinent data such as weight, height, BMI,
educational background, and other descriptive data that may place people at increased risks for
the development of hypertension. The current study used a limited sample size, which could not
represent the larger population. Therefore, there is a need to replicate the current findings using a
large sample size from other locations representing the larger population.
Plan for Dissemination
Dissemination of this DNP project results entails sharing the findings locally with
colleagues and other individuals within the larger workforce and community. Different
communication methods such as poster presentations, speaking at engagements, drafting a letter
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to state and national officials, and sharing on social media can be implemented. Potential
challenges in disseminating project results could include funding and not reaching out far
enough. The primary purpose of disseminating project results is to increase or promote the
spread of knowledge about evidence-based interventions to promote their greater application and
patient outcomes. One internal method that I will use to disseminate the current project findings
is by sharing the information with the workplace leadership and to advance this project by
implementing a workplace screening program for hypertension leading to other screening
programs.
The workplace clinic contains several employees at numerous clinics across the United
States, such as nurses, physicians, and other professionals within the occupational medicine
setting. To disseminate the program results to the various medical sites, I will use face-to-face
meetings, PowerPoint methods, and Zoom presentations. The approach is practical because it
promotes interactions and instant feedback during the questioning sessions.
Other methods for disseminating the current findings are by encouraging other team
members and providers to disseminate the information within their professional circle, to other
professionals, and to family and friends to have a broader outreach. Lastly, I will disseminate the
current project results using PowerPoint and presentations at my primary care worksite that is
combined with dentistry, which will allow interprofessional collaboration increasing patient
outreach.
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APPENDICES
Appendix A. Detailed Timeline
This DNP project received proposal approval from the committee on 05/02/2020. The
IRB process was initiated in Spring of 2021 and UNLVs IRB provided multiple
feedback/revision sessions via email, phone conversation, and portal submission prior to the final
approval granted in September 2021. September 16th, 2021, the project was initiated with
training of volunteer staff, followed by ongoing recruitment, enrollment which included the
initial visit, followed by a 30-day follow up in the end of January 2022. All participants were
informed the project was completed during their 30-day follow up visit, provided any additional
education and were advised to see their PCP for screening, monitoring, and/or maintenance of
their blood pressure.
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Appendix B. Detailed Project Tasks
The project tasks were completed in 4 phases.
Phase 1
10) NPs/PAs received education 30 days before the program start date, including a
refresher training on the AHA/ACC hypertension guidelines listed below:
g. Weight optimization, heart-healthy diet, sodium restriction, physical activity with
a structured exercise program, abstinence from or moderation of alcohol
consumption, and smoking cessation (Sharma et al., 2019).
h. The term prehypertension has been replaced with elevated blood pressure
(Sharma et al., 2019).
i. Elevated blood pressure is ranged from 120-129/80-89mm Hg, and stage 1
hypertension is greater than or equal to 130-139/80-89 mm Hg (Sharma et al.,
2019).
j. NPs/PAs, and MAs received all education materials that were to be provided to
participants.
vi.

How Can Physical Activity Become a Way of Life? (Appendix D)

vii.

Managing Blood Pressure with a Heart-Healthy Diet (Appendix E)

viii.

What is High Blood Pressure? (Appendix F.)

ix.

Blood Pressure Monitoring Sheet (Appendix G.)

x.

Hypertension Evaluation of Lifestyle and Management Scale (HELM)
(Appendix H.)
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k. All program materials were labeled workplace blood pressure program and filed
in a red folder placed in the medical records room labeled workplace blood
pressure program by the participating team members.
l. Participants who failed to follow up for an appointment were contacted by phone
to reschedule within 24 hours of their missed appointment.
Phase 2
11) The recruitment process involved enrolling participants on an ongoing basis.
a. Employees were recruited at their in-clinic evaluations for annual screenings
and follow-up visits.
b. The MA’s or Providers would then notify the PC about any employee with
elevated blood pressure.
12) Identified potential participants were then asked to voluntarily participate in the
Hypertension Screening Program. They were provided details about the program and
notified that this project would not affect their job position. All identified individuals
were recruited and enrolled in the program ongoing basis if they agreed to participate
and completed the informed consent. Participants were notified that they could stop
participating at any time and were not mandated to complete the study. Due to the
COVID-19 Pandemic, there were increased risks of contacting Covid-19 in
public/private settings. To decrease these risks, we followed CDC guidelines to
include: (a) completing an online Covid-19 screening sheet before being permitted
onsite, (b) asking all participants to stay home if sick and to report any new Covid-19
symptoms to occupational medicine, (c) social distancing at all times while on-site,
(d) wearing face coverings/face masks at all times while on-site and in the
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occupational medicine clinic, (e) completing a Covid-19 screening questionnaire
while in the occupational medicine clinic, (f) recommending frequent hand washing.
We provided multiple hand hygiene stations throughout the worksite and
occupational medicine clinic. At no cost, the Moderna vaccine was offered to all
employees to help prevent/reduce the spread of Covid-19, and all occupational
medicine providers were fully vaccinated. All occupational medicine providers wore
N-95 masks during patient encounters for this project for the safety of the participants
and staff. The participants were exposed to staff for less than 5 minutes during blood
pressure collection. Patient education, administration of the informed consent,
HELMS questionnaire, review of home blood pressure sheets, and referral occurred
in a patient room. The provider and participant were more than 6 feet apart
throughout the visit.
Phase 3
13) Blood pressure screenings were conducted by MAs trained in manual blood pressure
measurement. NPs/PAs trained in manual blood pressure measurement completed
blood pressure measurements if needed and during staff shortages. Participants who
agreed to participate with elevated blood pressure or stage 1 blood pressure reading
during their in-clinic visit completed the following steps on day 1 of the program: (a)
signed informed consent before participation, (b) had their second blood pressure
measured, and (c) completed a pre-HELM assessment reviewed by the NP/PA
completed during non-working hours. Participants who had a blood pressure of less
than 120/80 mm Hg during their second blood pressure measurement were notified
they no longer qualify for the study. The post-HELM assessment was administered
68

for comparison during the participants' 30-day evaluation. Blood pressures were
collected in the North Las Vegas clinic after a 5-minute resting interval to improve
the accuracy of the blood pressure. If participants had an SBP greater than 120-139
and DBP greater than 80-89 mm Hg, they required a repeat blood pressure.
14) Day 1 of the program was defined as the day each participant had their first elevated
blood pressure reading documented. On day 1 of the program, if the participant's
blood pressure was higher than 120/80 mm Hg. The MAs then notified the PC of the
elevated blood pressure. The PC then went and evaluated the employee, collected a
medical history and medication review, informed the employee of the study, and
asked them to voluntarily participate. If the employee agreed, they were consented
and started the program immediately. The MA then repeated the blood pressure and,
if elevated, waited for 5 minutes, repeated the blood pressure again, and documented
the last blood pressure as the second blood pressure reading. If the participant's blood
pressure remained higher than 120/80 mm Hg, they were informed to continue in the
program. If the participant's blood pressure was less than 120/80 mm Hg, they
remained in the room. A provider was notified to discuss the results and informed the
participant that they were not continuing in the program as their blood pressure had
normalized. However, we will still provide lifestyle modification education to educate
about disease prevention. If the patient had blood pressure between 120/80-139/89
mm Hg, the provider gave thorough patient education, followed the AHA/ACC
hypertension treatment guidelines, and followed the steps below:
a. Provided lifestyle modification education. This education included
hypertension education resources from the AHA on How Can Physical
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Activity Become a Way of Life? (Appendix D.), Managing Blood Pressure
with a Heart-Healthy Diet (Appendix E.), and “What is High Blood Pressure”
(Appendix F.).
b. Offered an in-depth discussion on hypertension and prevention and set
individualized goals. All participants were given resources to our wellness
center that provides free/discounted activities, including health education
sessions, cooking classes, exercise resources, and other benefits.
c. All participants were referred to their PCP for disease monitoring and other
preventive health screenings.
d. Participants were notified of their follow-up to include:
ii.

30-day follow-up appointment for blood pressure reassessment,
HBPM review, post-HELM assessment completion, repeat blood
pressure, provided average blood pressure reading, final participant
education session, and notification program completion.

e. All records were reviewed by the PC on an ongoing basis until program
completion and temporarily stored in a locked medical records office on the
work site.
15) After the participant education session, all participants received a Digital Blood
Pressure Monitoring Unit Drive upper arm monitoring device and a blood pressure
monitoring sheet to document their blood pressure.
a. Participants were educated on the use of the blood pressure machines and cuff
placement using the recommended instructions that come with the device.
Each Participant was monitored, providing a return demo on the use of the
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upper arm unit. This was completed to ensure they used the machine correctly
and identified early problems handling the device.
b. The NPs, PAs, and MAs received education on battery replacement, alarm
settings, and replacement cuffs.
c. Participants were advised to read all safety notices regarding testing
guidelines, unit operation, machine maintenance, and low battery indicator
information before use.
d. The participants were allowed to keep the blood pressure cuffs/devices at the
end of the self-home monitoring trial.
e. Participants were advised if the blood pressure machine's irregular heartbeat
indicator alarms frequently to consult with their PCP and notify occupational
medicine for further assessment.
16) Participants were instructed to monitor their blood pressure twice daily, once in the
morning and once at night at the same time every day if possible. The blood pressure
monitoring sheet included the date, time, SBP/DBP readings, and recorded data for
two weeks (Appendix G.). The blood pressure monitoring sheet included instructions
reminding participants to (a) sit in a calm area five minutes before blood pressure
reading, (b) avoid talking or eating, or excessive physical activity 30 minutes prior or
while monitoring blood pressure, (c) if blood pressure is higher than 120/80 mm Hg
to wait 1-2 minutes before repeating blood pressure, (d) measure their blood pressure
with the arm in a position that is leveled to the heart.
17) Participants with multiple blood pressures greater than 140/90 mm Hg without any
signs or symptoms were recommended to see their PCP or urgent care provider as
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soon as possible and explained the risks of prolonged hypertension. On multiple
readings, any participant with severe hypertension or blood pressure greater than
180/110 mm Hg was advised to follow up with their PCP, urgent care, or emergency
department for immediate evaluation and treatment if at home.
c. Emergency medical services would be notified if severe hypertension
occurred in the clinic. The participant would be referred to the emergency
room for immediate treatment.
d. Suppose participants refused to seek treatment for stage 2 hypertension or
higher. In that case, they would be given an Against Medical Advice Form
(AMA) to sign and informed of all risks but will not continue in the program.
18) Participants were instructed to bring their blood pressure monitoring sheet during
their scheduled 30-day follow-up to be reviewed by NPs and PAs for blood pressure
education and data collection purposes. Participants were scheduled and seen by a
provider on day 1 of the program and for a 30-day follow for a total of 2 visits.
Phase 4
a. Participants returned for their 30-day follow-up, which was their final visit.
The last blood pressure was collected and recorded, and the HBPM
monitoring sheet was reviewed. Each Participant was informed of their 2week average blood pressure range and provided additional education on
blood pressure management if requested. No diagnosis was provided during
this project. Participants were encouraged to continue the lifestyle
modification changes and periodic blood pressure monitoring. They were
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informed to follow up with their PCP or establish care with a PCP for
continuity of care.
b. All paper documents were scanned into a secure google drive account, where
they were pulled from the drive and stored on the PI’s secured drive. All files
were then deleted from google drive. All paper documents were securely
transported weekly to the PI’s office on UNLV Campus and stored in a locked
file cabinet.
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Appendix C. Budget
As previously stated, the PCs workplace covered all project costs which are listed
below:
1. Automated blood pressure machines- $35.00, 50 ordered, totaling- $1,750.00
2. Additional (large size) blood pressure cuffs- $14.00, 20 ordered, totaling- $280.00
3. Total cost- $ 2,030.00
4. Participants suffered no costs or fees by volunteering for this project.
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Appendix D. How Can Physical Activity Become a Way of Life?
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Appendix E. Managing Blood Pressure with a Heart-Healthy Diet
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Appendix F. What is High Blood Pressure?
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Appendix G. Blood Pressure Monitoring Sheet
Blood Pressure Monitoring Sheet
Identifier Number # OM- ____
Instructions:
(A) Sit in a calm area five minutes before blood pressure reading.
(B) Avoid talking or eating, or excessive physical activity 30 minutes prior or while
monitoring blood pressure.
(C) If blood pressure is higher than 120/80 mm Hg to wait 1-2 minutes before repeating
blood pressure.
(D) Measure their blood pressure with the arm in a position that is leveled to the heart.

14
Days
1
2
3
4
5
6
7
8
9
10
11
12
13
14

Date

Time/AM Systolic

Diastolic
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Time/PM Systolic

Diastolic

Appendix H. Hypertension Evaluation of Lifestyle and Management Scale (HELM)
This next series of questions are designed to test your knowledge of high blood pressure. You
may find many of them to be hard. This is OK, just do the best you can. I will give you the
answers today. Indicate if you think the statement is true or false.
D1. A person is considered to have hypertension if either their systolic
blood pressure is 140 or higher or their diastolic is 90 or higher on
two separate occasions.

True

False

D2. Most people can tell when their blood pressure is high because they True
feel bad.

False

D3. People with hypertension do not need to take medicine if they
exercise regularly.

True

False

D4. Most people with hypertension need more than one kind of blood
pressure medicine to control their blood pressure.

True

False

D5. Most of the salt Americans eat is added with a salt shaker.

True

False

D6. There are about as many calories in 12 ounces of regular orange
juice as there are in 12 ounces of regular cola.

True

False

For the next multiple-choice section, please choose only one answer for each
question. There are four possible answers for each question.
D7.

A man reports that his blood pressure (BP) is 148/78 when he checks it using the BP
machine in the pharmacy, 144/66 in his family doctor's office, and 132/74 when he
checks it at home. Which of the following statements is TRUE?
1. It is common for blood pressure readings to vary like this.
2. The highest blood pressure reading is the correct one.
3. The lowest blood pressure reading is the correct one.
4. He can be reassured that his blood pressure is normal.

D8.

Which one of the following increases your risk of having hypertension?
1. Weight lifting.
2. Drinking more than 2 cups of coffee a day.
3. Smoking a pack of cigarettes daily.
4. Gaining 15 pounds.

88

D9.

What is the goal blood pressure for a 70-year old man with no other health problems
who is taking medicine for hypertension?
1. Less than 120/80 mmHg.
2. Less than 130/86 mmHg.
3. Less than 160/90 mmHg.
4. Less than 140/90 mmHg.
D10. Blood pressure is measured with two numbers, an upper number and a lower number. It
is usually written as upper/lower. If someone is told that their goal blood pressure is 126/76,
when have they reached that goal?
1. When the upper is below 126 and the lower is below 76.
2. When the upper is below 126, even if the lower is over 76.
3. When the lower is below 76, even if the upper is over 126.
4. When the average of the upper and the lower is less than 100.
D11. An overweight 60-year old man has hypertension. He drinks one bottle of beer and 4 cups
of regular coffee a day. He adds regular table salt to his food at most meals.
Which one of the following changes is the most likely to lower his blood pressure?
1. Lose 10 pounds.
2. Stop drinking alcohol.
3. Switch to decaffeinated coffee.
4. Switch to sea salt.
D12. Uncontrolled hypertension can lead to which of the following:
1. Lung cancer.
2. Kidney failure.
3. High cholesterol.
4. Diabetes.
D13. A healthy 60-year old man has a blood pressure of 130/84. Which of the following
statements about his risk of developing hypertension by the time he is 80 is TRUE?
1. If a person has not developed hypertension by the age of 60, he won’t have it when he’s
80.
2. It would be very unusual for a person to first develop hypertension at the age of 80.
3. It would be very common for a person to first develop hypertension at the age of 80.
4. Everyone who lives to be 80 will eventually have hypertension.

D14. Which of the following statements about taking blood pressure medicine is TRUE?
1. Blood pressure medicine should always be taken with food.
2. More than one type of blood pressure medicine can be taken at the same time.
3. Blood pressure medicine works best if it is taken at bedtime.
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4. Blood pressure medicine should not be taken if a person drank alcohol that day.

D15. When measuring your blood pressure at home, you should:
1. Always take your reading before you take your blood pressure medicine.
2. Take several readings, a minute or two apart, and record the lowest one.
3. Take your blood pressure right after exercising and at least two hours after a meal.
4. Take two readings, a minute or two apart, and write down the average value.
D16. Which one of the following changes to your diet is most likely to lower blood pressure?
1.Eat more fruits, vegetables, whole grains and low-fat dairy products.
2. Eliminate spicy foods.
3. Drink one glass of red wine daily.
4. Drink herbal tea instead of coffee.
D17. Which one of the following statements about exercise and blood pressure is TRUE?
1. People who are on their feet most of the day will not benefit from more exercise.
2. Exercising for 30 minutes every day lowers blood pressure more than exercising for 30
minutes, 3 days a week.
3. Weight lifting should be avoided by people with high blood pressure.
4. When exercising, you must raise your heart rate to at least 100 beats a minute to
improve blood pressure.
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